• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

2005 Public Health Advisories

NeutroSpec (12/19/2005)

Paxil (paroxetine) (12/8/2005)

Serevent Diskus (salmeterol xinafoate inhalation powder), Advair Diskus (fluticasone propionate & salmeterol inhalation powder), Foradil Aerolizer (formoterol fumarate inhalation powder) (Long Acting Beta Agonists) (11/18/2005)

Strattera (9/29/2005)

Strengthened Risk Management Program for Isotretinoin (Accutane) (8/25/2005)

Mifexprex (mifepristone) (7/19/2005)

Duragesic (Fentanyl Transdermal System) (7/15/2005)

Palladone (hydromorphone hydrochloride, extended release capsules) (7/13/2005)

Suicidality in Adults Being Treated with Antidepressant Medications (6/30/2005)

Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances (4/11/2005)

FDA Announces Important Changes and Additional Warnings for COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (4/7/2005)

Crestor (3/2/2005)

Elidel (pimecrolimus) Cream and Protopic (tacrolimus) Ointment (3/10/2005)

Tysabri (2/28/2005)

Gabitril (2/18/2005)

Adderall (2/9/2005)

Viramune (1/19/2005)